Back to NRSNW
UBS Group AG NRSNW Position History
NeuroSense Therapeutics Ltd. • Healthcare
Quarters held
15
Latest value
$4K
Q3 2026
Peak value
$69K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $397 |
| Q3 2025 | $17K |
| Q3 2025 | $1K |
| Q4 2025 | $291 |
| Q4 2025 | $13K |
| Q4 2025 | $11K |
| Q1 2026 | $64 |
| Q1 2026 | $9K |
| Q1 2026 | $28K |
| Q2 2026 | $73 |
| Q2 2026 | $69K |
| Q2 2026 | $6K |
| Q2 2026 | $3K |
| Q3 2026 | $52 |
| Q3 2026 | $4K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4K | 985 | — | — |
| Q3 2026 | $52 | 1.2K | — | — |
| Q2 2026 | $3K | 4.8K | — | — |
| Q2 2026 | $6K | 7.8K | — | — |
| Q2 2026 | $69K | 96.0K | — | — |
| Q2 2026 | $73 | 1.2K | — | — |
| Q1 2026 | $28K | 37.1K | — | — |
| Q1 2026 | $9K | 12.0K | — | — |
| Q1 2026 | $64 | 1.2K | — | — |
| Q4 2025 | $11K | 13.8K | — | — |
| Q4 2025 | $13K | 17.1K | — | — |
| Q4 2025 | $291 | 1.2K | — | — |
| Q3 2025 | $1K | 888 | — | — |
| Q3 2025 | $17K | 13.8K | — | — |
| Q3 2025 | $397 | 1.3K | — | — |